Oncology Data AdvisorThe mission of Oncology Data Advisor is to provid Author: i3 Health
The mission of Oncology Data Advisor is to provide the multidisciplinary team with expert insights into clinical best practices and research progress in cancer care. Language: en Genres: Science Contact email: Get it Feed URL: Get it iTunes ID: Get it |
Listen Now...
AI-Driven Pathological Subtyping for Pancreatic Cancer: Moving From Promise to Practical Application
Monday, 4 May, 2026
Read the full article at: https://oncdata.com/ai-driven-pathological-subtyping-pancreatic-cancer-ashish-manne Artificial intelligence (AI) continues to generate excitement across oncology, but its real-world clinical impact remains uneven. In this episode of Exploring AI in Oncology, Dr. Ashish Manne, a Gastrointestinal Medical Oncologist at The Ohio State University Comprehensive Cancer Center, Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, shares his American Association for Cancer Research (AACR) presentation on AI-driven pathological subtyping in pancreatic cancer and highlights a critical shift: moving AI from theoretical promise to practical application.










